FDA lets 2 cancer drugs be imported
Dire shortages of two critical cancer drugs—shortfalls that have threatened the lives and care of thousands of patients—should be resolved within weeks, federal drug officials said. In the case of Doxil, the F.D.A. has decided to allow temporary shipments from India of Lipodox, which is similar to Doxil and is made by Sun Pharma Global. And the pharmaceutical company Hospira is rushing 31,000 vials—enough to last the entire nation a month—of preservative-free methotrexate from its plant in Australia to the United States. Hospitals began receiving the drug, which is vital in the treatment of a common form of childhood leukemia, on Tuesday.
- Governors Push to Expand Role of PAs, Telemedicine
- 3 More Pioneer ACOs Say They Will Quit
- Why Open Payments Irks Physicians
- Telemetry Overuse Cost Health System $4.8 Million in One Year
- Ebola in the U.S.: Reason to Fear, to Hope, to Prepare
- Top Provider Billing Mistakes Are Changing
- Overcoming a Payer Mix 'Nightmare'
- Employee Engagement: Make It Meaningful
- Difficult Patients: It's Not Them, It's You, Doctor
- IV Fluids Shortage Continues